Logo image of INDV

INDIVIOR PLC (INDV) Stock Fundamental Analysis

NASDAQ:INDV - GB00BN4HT335 - Common Stock

24.36 USD
-0.1 (-0.41%)
Last: 8/27/2025, 8:00:02 PM
24.42 USD
+0.06 (+0.25%)
After Hours: 8/27/2025, 8:00:02 PM
Fundamental Rating

4

Overall INDV gets a fundamental rating of 4 out of 10. We evaluated INDV against 193 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of INDV get a neutral evaluation. Nothing too spectacular is happening here. INDV is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year INDV was profitable.
INDV had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: INDV reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: INDV reported negative operating cash flow in multiple years.
INDV Yearly Net Income VS EBIT VS OCF VS FCFINDV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.00%, INDV is in the better half of the industry, outperforming 73.58% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 111.88%, INDV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INDV is significantly above the industry average of 15.38%.
The 3 year average ROIC (43.06%) for INDV is below the current ROIC(111.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4%
ROE N/A
ROIC 111.88%
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
INDV Yearly ROA, ROE, ROICINDV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 300 400

1.3 Margins

In the last couple of years the Profit Margin of INDV has declined.
INDV has a better Operating Margin (25.44%) than 92.23% of its industry peers.
INDV's Operating Margin has been stable in the last couple of years.
INDV's Gross Margin of 83.98% is amongst the best of the industry. INDV outperforms 89.64% of its industry peers.
INDV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 25.44%
PM (TTM) N/A
GM 83.98%
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
INDV Yearly Profit, Operating, Gross MarginsINDV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), INDV is creating value.
INDV has less shares outstanding than it did 1 year ago.
INDV has less shares outstanding than it did 5 years ago.
INDV has a worse debt/assets ratio than last year.
INDV Yearly Shares OutstandingINDV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
INDV Yearly Total Debt VS Total AssetsINDV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

INDV has an Altman-Z score of 3.34. This indicates that INDV is financially healthy and has little risk of bankruptcy at the moment.
INDV has a better Altman-Z score (3.34) than 73.58% of its industry peers.
The Debt to FCF ratio of INDV is 2.49, which is a good value as it means it would take INDV, 2.49 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of INDV (2.49) is better than 90.67% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.49
Altman-Z 3.34
ROIC/WACC10.9
WACC10.26%
INDV Yearly LT Debt VS Equity VS FCFINDV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

INDV has a Current Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of INDV (0.88) is worse than 83.94% of its industry peers.
INDV has a Quick Ratio of 0.88. This is a bad value and indicates that INDV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of INDV (0.72) is worse than 84.46% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.72
INDV Yearly Current Assets VS Current LiabilitesINDV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

1

3. Growth

3.1 Past

INDV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.28%.
The earnings per share for INDV have been decreasing by -29.07% on average. This is quite bad
Looking at the last year, INDV shows a small growth in Revenue. The Revenue has grown by 4.34% in the last year.
The Revenue has been decreasing by -4.53% on average over the past years.
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%

3.2 Future

The Earnings Per Share is expected to decrease by -15.65% on average over the next years. This is quite bad
INDV is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -6.61% yearly.
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INDV Yearly Revenue VS EstimatesINDV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
INDV Yearly EPS VS EstimatesINDV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

INDV is valuated correctly with a Price/Earnings ratio of 13.92.
Based on the Price/Earnings ratio, INDV is valued cheaply inside the industry as 87.56% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of INDV to the average of the S&P500 Index (27.14), we can say INDV is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 14.31, the valuation of INDV can be described as correct.
80.83% of the companies in the same industry are more expensive than INDV, based on the Price/Forward Earnings ratio.
INDV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.80.
Industry RankSector Rank
PE 13.92
Fwd PE 14.31
INDV Price Earnings VS Forward Price EarningsINDV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

INDV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. INDV is cheaper than 97.93% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of INDV indicates a rather cheap valuation: INDV is cheaper than 82.90% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 23.03
EV/EBITDA 5.48
INDV Per share dataINDV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

INDV's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of INDV may justify a higher PE ratio.
A cheap valuation may be justified as INDV's earnings are expected to decrease with -10.28% in the coming years.
PEG (NY)1.72
PEG (5Y)N/A
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%

More info and screens

0

5. Dividend

5.1 Amount

INDV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INDIVIOR PLC

NASDAQ:INDV (8/27/2025, 8:00:02 PM)

After market: 24.42 +0.06 (+0.25%)

24.36

-0.1 (-0.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-23 2025-10-23
Inst Owners86.46%
Inst Owner Change18.8%
Ins Owners3.78%
Ins Owner ChangeN/A
Market Cap3.04B
Analysts82.5
Price Target14.88 (-38.92%)
Short Float %5.94%
Short Ratio2.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 13.92
Fwd PE 14.31
P/S 1.48
P/FCF 23.03
P/OCF 18.31
P/B N/A
P/tB N/A
EV/EBITDA 5.48
EPS(TTM)1.75
EY7.18%
EPS(NY)1.7
Fwd EY6.99%
FCF(TTM)1.06
FCFY4.34%
OCF(TTM)1.33
OCFY5.46%
SpS16.51
BVpS-2.28
TBVpS-2.34
PEG (NY)1.72
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4%
ROE N/A
ROCE 141.62%
ROIC 111.88%
ROICexc N/A
ROICexgc N/A
OM 25.44%
PM (TTM) N/A
GM 83.98%
FCFM 6.41%
ROA(3y)-3.2%
ROA(5y)-1.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)43.06%
ROIC(5y)30.49%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)54.5%
ROCE(5y)38.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.47%
OM growth 5Y-1.25%
PM growth 3Y-81.34%
PM growth 5Y-60.3%
GM growth 3Y0.52%
GM growth 5Y0.74%
F-Score5
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.49
Debt/EBITDA 0.57
Cap/Depr 136%
Cap/Sales 1.65%
Interest Coverage 250
Cash Conversion 30.24%
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.72
Altman-Z 3.34
F-Score5
WACC10.26%
ROIC/WACC10.9
Cap/Depr(3y)163.83%
Cap/Depr(5y)132.28%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.28%
EPS 3Y-29.07%
EPS 5YN/A
EPS Q2Q%15.91%
EPS Next Y8.11%
EPS Next 2Y-1.39%
EPS Next 3Y-10.28%
EPS Next 5Y-15.65%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y-4.53%
Revenue growth 5YN/A
Sales Q2Q%1%
Revenue Next Year3.53%
Revenue Next 2Y-2.92%
Revenue Next 3Y-9.06%
Revenue Next 5Y-6.61%
EBIT growth 1Y103.89%
EBIT growth 3Y11.69%
EBIT growth 5Y7.28%
EBIT Next Year13.79%
EBIT Next 3Y10.08%
EBIT Next 5Y12.03%
FCF growth 1Y473.91%
FCF growth 3Y-74.97%
FCF growth 5Y-48.94%
OCF growth 1Y374.29%
OCF growth 3Y-53.28%
OCF growth 5Y-24.93%